Carmat SA (ALCAR.PA)
EUR 1.0
(-1.09%)
EUR 1.0
(-1.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -52.51 Million EUR | -0.86% |
| 2022 | -52.05 Million EUR | 13.84% |
| 2021 | -60.41 Million EUR | -65.93% |
| 2020 | -36.41 Million EUR | 14.14% |
| 2019 | -42.4 Million EUR | 0.87% |
| 2018 | -42.78 Million EUR | -37.72% |
| 2017 | -31.06 Million EUR | -26.06% |
| 2016 | -24.64 Million EUR | -24.87% |
| 2015 | -19.73 Million EUR | 0.68% |
| 2014 | -19.86 Million EUR | -23.28% |
| 2013 | -16.11 Million EUR | 28.0% |
| 2012 | -22.38 Million EUR | -39.12% |
| 2011 | -16.09 Million EUR | -53.51% |
| 2010 | -10.48 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -25.4 Million EUR | 0.0% |
| 2023 Q2 | -33.57 Million EUR | 0.0% |
| 2023 Q4 | -45.59 Million EUR | 0.0% |
| 2023 FY | -52.5 Million EUR | -0.86% |
| 2022 FY | -52.05 Million EUR | 13.84% |
| 2022 Q2 | -25.2 Million EUR | 0.0% |
| 2022 Q4 | -26.85 Million EUR | 0.0% |
| 2021 Q4 | -34.87 Million EUR | 0.0% |
| 2021 FY | -60.41 Million EUR | -65.93% |
| 2021 Q2 | -25.54 Million EUR | 0.0% |
| 2020 Q4 | -15.83 Million EUR | 0.0% |
| 2020 Q2 | -20.57 Million EUR | 0.0% |
| 2020 FY | -36.41 Million EUR | 14.14% |
| 2019 Q2 | -23.69 Million EUR | 0.0% |
| 2019 Q4 | -18.71 Million EUR | 0.0% |
| 2019 FY | -42.4 Million EUR | 0.87% |
| 2018 FY | -42.78 Million EUR | -37.72% |
| 2018 Q2 | -19.39 Million EUR | 0.0% |
| 2018 Q4 | -23.38 Million EUR | 0.0% |
| 2017 Q2 | -14.71 Million EUR | 0.0% |
| 2017 FY | -31.06 Million EUR | -26.06% |
| 2017 Q4 | -16.32 Million EUR | 0.0% |
| 2016 Q2 | -11.29 Million EUR | 0.0% |
| 2016 FY | -24.64 Million EUR | -24.87% |
| 2016 Q4 | -13.28 Million EUR | 0.0% |
| 2015 FY | -19.73 Million EUR | 0.68% |
| 2015 Q4 | -10.59 Million EUR | 0.0% |
| 2015 Q2 | -9.16 Million EUR | 0.0% |
| 2014 FY | -19.86 Million EUR | -23.28% |
| 2014 Q2 | -10.69 Million EUR | 0.0% |
| 2014 Q4 | -9.17 Million EUR | 0.0% |
| 2013 Q1 | -4.01 Million EUR | 0.0% |
| 2013 Q4 | -10.35 Million EUR | -157.92% |
| 2013 FY | -16.11 Million EUR | 28.0% |
| 2013 Q3 | -4.01 Million EUR | 30.4% |
| 2013 Q2 | -5.76 Million EUR | -43.67% |
| 2012 Q4 | -4.01 Million EUR | 26.91% |
| 2012 Q1 | -5.49 Million EUR | 0.0% |
| 2012 FY | -22.38 Million EUR | -39.12% |
| 2012 Q3 | -5.49 Million EUR | 0.0% |
| 2012 Q2 | -5.49 Million EUR | 0.0% |
| 2011 Q1 | -3.95 Million EUR | 0.0% |
| 2011 Q3 | -3.95 Million EUR | 0.0% |
| 2011 Q4 | -5.49 Million EUR | -38.87% |
| 2011 FY | -16.09 Million EUR | -53.51% |
| 2011 Q2 | -3.95 Million EUR | 0.0% |
| 2010 FY | -10.48 Million EUR | 0.0% |
| 2010 Q4 | -3.95 Million EUR | -51.83% |
| 2010 Q1 | -2.6 Million EUR | 0.0% |
| 2010 Q3 | -2.6 Million EUR | 0.0% |
| 2010 Q2 | -2.6 Million EUR | 0.0% |
| 2009 Q4 | -2.6 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Affluent Medical SA | -13.06 Million EUR | -301.952% |
| Bluelinea Société Anonyme | -1.61 Million EUR | -3156.661% |
| Diagnostic Medical Systems S.A. | -2.26 Million EUR | -2218.72% |
| Euromedis Groupe | -5.55 Million EUR | -845.064% |
| Eurobio Scientific Société anonyme | 10.14 Million EUR | 617.888% |
| Ikonisys S.A. | -2.19 Million EUR | -2294.051% |
| Implanet S.A. | -6.15 Million EUR | -752.72% |
| Median Technologies SA | -23 Million EUR | -128.284% |
| SpineGuard SA | -3.97 Million EUR | -1220.869% |
| Theraclion SA | -3.15 Million EUR | -1565.155% |
| Euroapi S.A. | -234.3 Million EUR | 77.585% |
| Guerbet SA | 38.67 Million EUR | 235.81% |
| Ion Beam Applications SA | 5.09 Million EUR | 1131.402% |
| Koninklijke Philips N.V. | -115 Million EUR | 54.331% |
| Sequana Medical NV | -29.49 Million EUR | -78.082% |